Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2011 by Technische Universität Dresden.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Jörg Kotzerke, Dresden University of Technology Identifier:
First received: September 13, 2005
Last updated: August 23, 2011
Last verified: August 2011

The purpose of this study is to describe the regional and global tumor hypoxia in head-and-neck cancer during percutaneous radiation therapy

Condition Phase
Head and Neck Neoplasms
Phase 2

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO

Resource links provided by NLM:

Further study details as provided by Technische Universität Dresden:

Estimated Enrollment: 20
Study Start Date: July 2006

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

The study includes consecutive patients from the Department of Radiooncology with head and neck cancer (HNC) intended for a curative chemoradiotherapy.


Inclusion Criteria:

  • histologically confirmed head-and-neck cancer not curable by surgery
  • Karnofsky > 70%
  • tumor volume and localisation allow curative radiotherapy
  • written consent

Exclusion Criteria:

  • metastases
  • earlier radiation therapy of head and neck
  • pregnancy
  • secondary malignancy excluding dermal carcinoma and Tis-carcinoma of cervix uteri
  • psychiatric impairment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00180180

Contact: Joerg Kotzerke, MD +49 351 458 4160

Department of Nuclear Medicine Recruiting
Dresden, Germany, 01307
Contact: Joerg Kotzerke, MD    +49 351 458 4160   
Sponsors and Collaborators
Technische Universität Dresden
Principal Investigator: Joerg Kotzerke, MD Department of Nuclear Medicine
  More Information

No publications provided

Responsible Party: Jörg Kotzerke, Prof. Dr., Dresden University of Technology Identifier: NCT00180180     History of Changes
Other Study ID Numbers: HNO-FMISO-FU
Study First Received: September 13, 2005
Last Updated: August 23, 2011
Health Authority: Germany: Fedaral Office for Radiation Protection

Keywords provided by Technische Universität Dresden:
head-and-neck cancer
radiation therapy

Additional relevant MeSH terms:
Head and Neck Neoplasms
Neoplasms by Site processed this record on March 03, 2015